Parallel Advisors’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Parallel Advisors’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-62	Closed	-$3K	–	2814
2020 Q3	$3K	Buy	62 +17	+38%	+$1.05K	﹤0.01%	2245
2020 Q2	$2K	Hold	45	–	–	﹤0.01%	2269
2020 Q1	$2K	Buy	45 +23	+105%	+$1.31K	﹤0.01%	2212
2019 Q4	$1K	Hold	22	–	–	﹤0.01%	2386
2019 Q3	$1K	Hold	22	–	–	﹤0.01%	2366
2019 Q2	$1K	Hold	22	–	–	﹤0.01%	2281
2019 Q1	$1K	Hold	22	–	–	﹤0.01%	2252
2018 Q4	$1K	Hold	22	–	–	﹤0.01%	2089
2018 Q3	$1K	Hold	22	–	–	﹤0.01%	2192
2018 Q2	$0	Buy	+22	New	+$946	﹤0.01%	2256

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Parallel Advisors's BSTC Position: Q4 2020 in Review

Parallel Advisors sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 62 shares — an estimated $3K sold.

Parallel Advisors first reported a position in BSTC in Q2 2018 and held it in 10 quarters. The position peaked at $3K in Q3 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Parallel Advisors reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Parallel Advisors sold 62 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $3K.
Parallel Advisors first reported a position in BioSpecifics Technologies Corp. in Q2 2018 and held it in 10 quarters.
Parallel Advisors's BioSpecifics Technologies Corp. position peaked at $3K in Q3 2020.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Parallel Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.